Skip to main content

Table 2 Synergistic antimicrobial activity between AKBA and GEN against MRSA and MSSA clinical isolates

From: Drug repurposing: insights into the antimicrobial effects of AKBA against MRSA

Strains

Resistant Pattern

Antimicrobial

MICalone

Fold Change

MICin combination

FICI

Outcome

SA2301

MRSA

AKBA

8

2

0.25

0.5

Synergy

GEN

16

4

0.25

SA2302

MRSA

AKBA

8

1

0.125

0.25

Synergy

GEN

32

4

0.125

SA2303

MRSA

AKBA

8

2

0.25

0.375

Synergy

GEN

16

2

0.125

SA2304

MRSA

AKBA

8

2

0.25

0.5

Synergy

GEN

16

4

0.25

SA2305

MRSA

AKBA

8

0.5

0.063

0.188

Synergy

GEN

> 32

4

0.125

SA2306

MRSA

AKBA

8

2

0.25

0.313

Synergy

GEN

32

2

0.063

SA2307

MRSA

AKBA

4

0.5

0.125

0.188

Synergy

GEN

32

2

0.063

SA2308

MRSA

AKBA

8

2

0.25

0.281

Synergy

GEN

32

1

0.031

SA2309

MRSA

AKBA

8

2

0.25

0.375

Synergy

GEN

32

4

0.125

SA2310

MRSA

AKBA

4

1

0.25

0.375

Synergy

GEN

16

2

0.125

SA23101

MSSA

AKBA

4

1

0.25

0.375

Synergy

GEN

2

0.25

0.125

SA23102

MSSA

AKBA

4

1

0.25

0.5

Synergy

GEN

2

0.5

0.25

SA23103

MSSA

AKBA

8

1

0.125

0.375

Synergy

GEN

4

1

0.25